Norway· NO-ID_C5C31834-793C-4A76-88E5-EE08C0D33068

Gefitinib mylan

A gefitinib product containing gefitinib, registered in Norway by Mylan. The same ATC class is registered in 13 of our 19 countries.

ATC L01EB01

Checked against FEST (Norway) on September 25, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about gefitinibAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Gefitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01EB01 (gefitinib), each read from that country’s own register.

This record: Norway, from FEST (Norway)
8 of them publish a price we can compare per daily dose

Search gefitinib products by name

Gefitinib · ATC L01EB01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gefitinib costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Gefitinib · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

CH Switzerland$95.15

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)

Active substance: Gefitinib
Manufacturer: Mylan
Country: Norway (NO)
ATC code: L01EB01
ATC class: Gefitinib
Defined daily dose: 0.25 g, O
Reimbursed: Not published by this register
Source register: FEST (Norway)
Last checked: September 25, 2026

Packs & prices · 3

no_merkevare_id
ID_C5C31834-793C-4A76-88E5-EE08C0D33068
no_varenummer
361620
30
gtin
7046264486351

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

414 interactions on record for gefitinib.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check gefitinib against other medicines How interaction checks work

Gefitinib · interactions on record

414 records

11 severe
193 moderate
5 minor
205 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
PexidartinibL01EX15severe
Aminolevulinic acidL01XD04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gefitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gefitinib products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Gefitinib Accord
Belgium · Gefitinib Accord, Gefitinib Sandoz
Bulgaria · Фромпо
Cyprus · Refetib
Czechia · Gefitinib Accord
Germany · Gefitinib Accord, Gefitinib Genthon
Denmark · Gefitinib Accord, Gefitinib Stada
Estonia · Gefitinib Auxilia, Gefitinib Norameda
Spain · Gefitinib Efg Genthon, Gefitinib Eugia
Finland · Gefitinib Accord, Gefitinib Stada
France · Gefitinib Arrow, Gefitinib Biogaran
United Kingdom (Northern Ireland) · Gefitinib Accord, Gefitinib Eugia (Uk)
Greece · Gefitinib Faran, Gefitinib Genepharm
Croatia · Gefitinib Pliva, Gefitinib Sandoz
Hungary · Gefitinib Genepharm, Gefitinib Onkogen
Iceland · Gefitinib Stada, Gefitinib Wh
Italy · Gefitinib Medac
Liechtenstein · Iressa
Lithuania · Gefitinib Norameda
Latvia · Gefitinib Norameda
Malta · Gefitinib Eugia, Gefitinib Genthon
Netherlands · Gefitinib Eugia, Gefitinib Genthon
Poland · Gefitinib Accord, Gefitinib Genthon
Portugal · Gefitinib Accord, Gefitinib Eugia
Romania · Gefitinib Accord, Gefitinib Polisano
Sweden · Gefitinib Accord, Gefitinib Stada
Slovenia · Phrompo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d77a0edb-4e80-476b-919a-ac2050b7520e
GET /v1/drugs/d77a0edb-4e80-476b-919a-ac2050b7520e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Gefitinib",
  "merkevare_id": "ID_C5C31834-793C-4A76-88E5-EE08C0D33068",
  "name_form_strength": "Gefitinib mylan tab 250 mg",
  "prescription_group": "C"
}

API reference MCP server Plans

See everything about gefitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console